Ambulatory blood pressure monitoring early after acute myocardial infarction: Development of a new prognostic index

Blood Pressure Monitoring

Volumn 12, Issue 2, 2007, Pages 69-74

  Antonini, Lanfranco ^a,b   Pasceri, Vincenzo ^a   Greco, Salvatore ^a   Colivicchi, Furio ^a   Malfatti, Solferina ^a   Pede, Sergio ^a   Guido, Vincenzo ^a   Kol, Amir ^a   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Heart failure; Myocardial infarction; Prognostic index

Indexed keywords

CREATININE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK; RISK REDUCTION; ST SEGMENT ELEVATION;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STROKE VOLUME;

EID: 33947143730     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e3280b08331     Document Type: Article

References (25)

1. Lee L, Woodlief L, Topol EJ. Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO 1 investigators. Circulation 1995; 91:1659-1668.
2. Antonini L, Colivicchi F, Greco S. Ambulatory blood pressure monitoring after acute myocardial infarction. Development of a new prognostic index. High Blood Press Cardiov Prev 2003; 10:75-80.
3. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59:607-609.
4. White WB, Lund-Johansen P, Omvik P. Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol 1990; 65:60-65.
5. Shiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H, et al. Left ventricular volume for paired biplane two-dimensional echocardiography. Circulation 1979; 60:547-555.
6. Schwarts KM. Limited exercise testing soon after myocardial infarction: correlation with early coronary and left ventricular angiography. Ann Intern Med 1981; 94:727-734.
7. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condors WR. Comparison of adenosine, dipyridamole and dobutamine in stress echocardiography. Ann Intern Med 1992; 116:190-196.
8. Gomes JA, Winters SL, Martinson M, Mahac J, Stewart D, Targonsky A. The prognostic significance of quantitative signal-averaged variables to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats. A prospective study. J Am Coll Cardiol 1989; 13:377-384.
9. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57:1074-1077.
10. Zuanetti G, Neison JMM, Latini R, Santoro E, Maggioni AP, Edwing DJ, on behalf of the GISSI-2 investigators. Prognostic significance of heart rate variability in post myocardial infarction patients in the fibrinolytic era. Circulation 1996; 94:432-436.
11. La Rovere MT, Bigger JT, Marcus F, Mortasa A, Schwartz PJ, for ATRAMI investigators. Baroreflex sensitivity and heart rate variability in prediction of total mortality after myocardial infarction. Lancet 1998; 35:478-484.
12. Volpi A, De Vita C, Franzosi MG, for the GISSI-2 investigators. Determinants of six-months mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation 1993; 88:416-429.
13. Wolffenbuttel BHR, Verdouw PD, Hugenholtz PG. Immediate and two year prognosis after acute myocardial infarction: prediction from non invasive as well as invasive parameters in the same individuals. Eur Heart J 1981; 2:375-387.
14. Kornowski R, Goldbourt U, Zion M, Mandelzweig L, Kaplinsky E, Levo Y, et al. for the SPRINT Study Group. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. Am J Cardiol 1993; 72:883-888.
15. Maeland JG, Meen K. Predicting long term mortality after myocardial infarction from routine hospital data. Acta Med Scand 1988; 224:539-547.
16. Jacobs DR, Kroenke C, Crow R, Deshpande M, Feng DG, Gatewood L, et al. PREDICT: a simple risk score for clinical severity and long term prognosis after hospitalization for acute myocardial infarction or unstable angina. The Minnesota Heart survey. Circulation 1999; 100:599-607.
17. Bassett D, Howley E. Maximal oxygen uptake: classical versus contemporary viewpoints. Med Sci Sports Exerc 1997; 29:591-597.
18. Gruppo Italiano per lo studio della sopravvivenza nell'infarto miocardico. GISSI-GI2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 1990; 336:65-71.
19. Gruppo Italiano per lo studio della sopravvivenza nell'Infarto Miocardico. GISSI-GIS3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after myocardial infarction. Lancet 1994; 343:1115-1122.
20. D'Agostino RB, Belanger AJ, Kannel WB, Cruckshank JM. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. Br Med J 1991; 303:385-389.
21. Flack JM, Neaton J, Grimm R, from the Multiple Risk Factor Intervention Trial Research Group. Blood pressure and mortality among men with prior myocardial infarction. Circulation 1995; 92:2437-2445.
22. Collins R, Peto R, MacMahon S. Blood pressure, stroke and coronary heart disease. Part II. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
23. Herbert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153:578-584.
24. Polese A, De Cesare N, Montorsi P. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 1991; 83:845-853.
25. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998; 280:623-629.